Generic sterile injectable drug product is one of the key ingredients of modern medicine. This type of drug can be produced without using original compounds or processing them at all. The pharmaceutical industries produce large quantities of generic medicines that are used to treat various diseases. Some countries also export their products which are used in Third World countries for treatment the process of manufacturing generic sterile injectable is equivalent in the terms of the FDA regulations to that of the branded counterparts. A disease is characterized as chronic if it lasts for over three months within the patient according to the U.S. National Center for Health Statistics. The chronic diseases are one of the major causes of mortality as these diseases cannot easily be cured by vaccines and healthcare medication.
The global generic sterile injectable market was valued at US$ 42,900 million in 2015 and is expected to witness a CAGR of 10.2% during the forecast period (2017–2025).
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/519
Increasing prevalence of chronic diseases and rapidly growing geriatric population that are highly susceptible to chronic diseases are the factors impacting growth of generic sterile injectable market in North America region. Moreover, growing instance of chronic disorders such as cancer and diabetes as well as the consequent rise in demand for newer generic injectable across various countries in Europe would further foster growth of the market in the region.
However, strict regulations by U.S. FDA such as, monitoring of the flexible intravenous (IV) solution bags from exposure to rough surfaces during labelling and packaging for any microscopic punctures or holes on the surface of the bag in order to avoid the microscopic defects that may lead to microbial contamination is expected to restrict growth of the market. However, the branded counterpart of the generic sterile injectable is more expensive and thus, cannot be afforded by a common population. Difficulties faced by manufacturing companies, in order to meet rising demands for these injectable in the hospitals, pharmacies, and drugs stores is one of the major concerns that may result in hampering the growth of the market. Whereas, various key holders are engaged in acquiring small pharmaceutical companies to build a robust product portfolio of generic sterile injectable to fulfill the demand of these medications.
Key players indulged in strategic implementation of various policies for the product portfolio expansion of the generic sterile injectable
In February 2021, Centrient Pharmaceuticals (“Centrient”), announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”), a global manufacturer specialised in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens its position as the global business-to-business industry leader in beta-lactam antibiotics.
Baxter in 2017, has also signed an agreement with Dorizoe, an India based life sciences company manufacturing generic sterile injectable. The duo is expected to develop more than 20 generic injectable products including oncolytic and cardiovascular medicines.
In July 2019, Fresenius Kabi, in 2016, Nexus Pharmaceuticals announced investment of $250 million in a 10-year, multi-phase project to build a sterile injectable manufacturing facility in Pleasant Prairie, Wisconsin, to address drug shortages “that have plagued the market for years of critical-need, life-saving sterile injectable medications
In September 2021, Hikma Pharma has announced the acquisition of Custopharm Inc. from Water Street Healthcare Partners Custopharm, a US-based generic sterile injectables company.
Major Players in Generic Sterile Injectable Market
Baxter Inc., Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy’s, Mylan, AstraZeneca Plc and Merck & Co. Inc.
Ask for PDF sample copy of the report @
https://www.coherentmarketinsights.com/insight/request-pdf/519
Reasons to Purchase this Report
• To gain an in-depth understanding of Generic Sterile Injectable market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Generic Sterile Injectable market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/519
Table of Content
Global Generic Sterile Injectable Market Research Report
Section 1: Global Generic Sterile Injectable Industry Overview
Section 2: Global Economic Impact on Generic Sterile Injectable Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Generic Sterile Injectable Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Generic Sterile Injectable Market Forecast
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837